• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Eitan Medical Receives FDA Clearance for Sapphire Infusion System

    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial

    RSIP Vision Announces Versatile Medical Image Segmentation Tool

    Vance Street Capital Adds Operating Partner

    Haemonetics to Acquire Cardiva for Up to $510M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Qosina Corp.

    Creganna Medical, part of TE Connectivity

    Medicoil

    Spectrum Plastics Group

    MW Life Sciences
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Concise Engineering

    MW Life Sciences

    Creganna Medical, part of TE Connectivity

    Unicep

    PTI Engineered Plastics Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Second Sight Medical Products Appoints Board Chairman

    New leader has served as president, chairman, CEO of Williams International Corporation.

    Related CONTENT
    • 121nexus Appoints Executive Vice President and Chief Operating Officer
    • Lantheus Holdings Appoints Three New Board Members
    • AtriCure Names Board Chairman
    • Integer Adds Financial Executive to its Board of Directors
    • BioSig Technologies Appoints New Chief Financial Officer
    Business Wire04.17.18
    Second Sight Medical Products Inc., a developer, manufacturer and marketer of implantable visual prosthetics, announced its Board of Directors has appointed Gregg Williams as chairman, effective immediately. Williams, a current board member and the company’s largest shareholder, succeeds Dr. Robert “Bob” Greenberg, who has served as board chairman since August 2015 and who remains a board member.
     
    “It has been my pleasure to work alongside Bob in his role as chairman and we appreciate his contributions in this leadership position as we have advanced Second Sight’s mission of treating all forms of blindness,” stated Will McGuire, president and CEO of Second Sight. “As a valued member of our Board of Directors, Gregg provides thoughtful leadership, extensive business expertise and a focus on commercial success to the Second Sight team. I look forward to continuing to work closely with Gregg and other members of the board as we execute our commercial and R&D strategies to deliver innovative technologies for the blind that build shareholder value.”
     
    “Over the last several years, under the leadership of Will McGuire, the company has built a team that has successfully transitioned Second Sight from a predominantly R&D focused organization to a fully capable commercial operation. The team’s demonstrated achievements in growing the number of worldwide Argus II Retinal Prosthesis Systems (Argus II), continued advancement and clinical testing of next generation Argus II technology aimed at treating better vision individuals, and now the highly encouraging initial clinical results of the potentially revolutionary Orion Cortical Visual Prosthesis System, provides me with great conviction that Second Sight is on the right path. I am confident that through our efforts to deliver products that potentially can treat nearly all forms of blindness, we will build and deliver strong long-term value to our shareholders. I look forward to continuing to work with the rest of the board, Will, and his management team to accelerate our progress towards full commercial success,” Williams said in his first official statement as board chairman.
     
    Williams joined Second Sight’s Board of Directors in June 2009. He has served as the as chairman, president, and CEO of Williams International Corporation since April 2005. He also serves as a director of the General Aviation Manufacturers Association.
     
    Second Sight develops, manufactures and markets implantable visual prosthetics to enable blind individuals to achieve greater independence. Second Sight has developed, and now manufactures and markets, the Argus II Retinal Prosthesis System. Development of new hardware and software intended to improve the quality of the vision produced by the Argus system is ongoing. Second Sight is also developing the Orion Visual Cortical Prosthesis to restore some vision to individuals who are blind due to many causes other than preventable or treatable conditions. Second Sight’s U.S. headquarters is in Sylmar, Calif., and its European headquarters is in Lausanne, Switzerland.

    Second Sight's Argus II System provides electrical stimulation that bypasses defunct retinal cells and stimulates remaining viable cells inducing visual perception in individuals with severe to profound retinitis pigmentosa (RP). The Argus II works by converting images captured by a miniature video camera mounted on the patient's glasses into a series of small electrical pulses, which are transmitted wirelessly to an array of electrodes implanted on the surface of the retina. These pulses stimulate the retina's remaining cells, intending to result in the perception of patterns of light in the brain. The patient must learn to interpret these visual patterns, having the potential to regain some visual function. The Argus II was the first artificial retina to receive widespread commercial approval, and is offered at approved centers in Canada, France, Germany, Italy, Russia, Saudi Arabia, Singapore, South Korea, Spain, Taiwan, Turkey, the United Kingdom, and the United States.
     
    Like the Argus II, the Orion converts images captured by a miniature video camera mounted on the patient's glasses into a series of small electrical pulses. The Orion is designed to transmit these electrical pulses wirelessly to an array of electrodes implanted on the surface of the visual cortex, intended to result in the perception of patterns of light. By bypassing the retina and optic nerve and directly stimulating the visual cortex, a cortical prosthesis system has the potential to restore useful vision to many more patients than the Argus II, including patients completely blinded due to many reasons, including glaucoma, diabetic retinopathy, or forms of cancer and trauma. The company has initiated a feasibility study in the United States at two centers: the Ronald Reagan UCLA Medical Center and Baylor College of Medicine in Houston. The first-in-human subject was implanted and activated as part of the first-in-human clinical studies with the Orion in 2018. No clinical data is yet available for the Orion.
    Related Searches
    • first
    • corporation
    • glaucoma
    • ucla
    Suggested For You
    121nexus Appoints Executive Vice President and Chief Operating Officer 121nexus Appoints Executive Vice President and Chief Operating Officer
    Lantheus Holdings Appoints Three New Board Members Lantheus Holdings Appoints Three New Board Members
    AtriCure Names Board Chairman AtriCure Names Board Chairman
    Integer Adds Financial Executive to its Board of Directors Integer Adds Financial Executive to its Board of Directors
    BioSig Technologies Appoints New Chief Financial Officer BioSig Technologies Appoints New Chief Financial Officer
    Bovie Medical Corporation Appoints CEO Bovie Medical Corporation Appoints CEO
    IP Veteran Joins BioSig Technologies’ Board of Directors IP Veteran Joins BioSig Technologies’ Board of Directors
    Second Sight Receives FDA Expedited Access Pathway Designation for Cortical Visual Prosthesis Second Sight Receives FDA Expedited Access Pathway Designation for Cortical Visual Prosthesis
     Second Sight Receives FDA Approval to Begin First Orion Human Clinical Study Second Sight Receives FDA Approval to Begin First Orion Human Clinical Study
     CRO Industry Veteran Joins SynteractHCR Board of Directors CRO Industry Veteran Joins SynteractHCR Board of Directors
    Second Sight Medical Products Adds to its Executive Team Second Sight Medical Products Adds to its Executive Team
    Second Sight Gets German Approval to Begin Argus II Study Second Sight Gets German Approval to Begin Argus II Study
    AtriCure Founder Joins Genetesis Board of Directors AtriCure Founder Joins Genetesis Board of Directors
    BioSig Technologies Hires Chief Commercialization Officer BioSig Technologies Hires Chief Commercialization Officer

    Related Breaking News

    • Evonik Closes LACTEL Absorbable Polymers Acquisition

      Evonik Closes LACTEL Absorbable Polymers Acquisition

      LACTEL's biodegradable, PLGA-based polymers will be integrated into Evonik’s Health Care business.
      Evonik 01.21.21

    • Eitan Medical Receives FDA Clearance for Sapphire Infusion System

      Eitan Medical Receives FDA Clearance for Sapphire Infusion System

      Upgraded infusion system provides advanced performance and customization capabilities within hospital, pre-hospital and ambulatory environments.
      Eitan Medical 01.20.21

    • Materials
      Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial

      Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial

      Enables both the rate at which it degrades in the body and its mechanical properties to be controlled independently.
      University of Birmingham 01.20.21


    • Diagnostics
      RSIP Vision Announces Versatile Medical Image Segmentation Tool

      RSIP Vision Announces Versatile Medical Image Segmentation Tool

      Delivers efficient anatomical measurements and better treatment options.
      RSIP Visions 01.20.21

    • Vance Street Capital Adds Operating Partner

      Vance Street Capital Adds Operating Partner

      J. Mark King will work closely with leadership teams of portfolio companies in the medical vertical.
      Vance Street Capital LLC 01.20.21

    • Cardiovascular | Surgical
      Haemonetics to Acquire Cardiva for Up to $510M

      Haemonetics to Acquire Cardiva for Up to $510M

      Enhances penetration into the large and growing interventional cardiology and electrophysiology markets.
      PR Newswire 01.20.21


    • Cardiovascular | Surgical
      Abbott Wins Expanded Medicare Coverage for MitraClip

      Abbott Wins Expanded Medicare Coverage for MitraClip

      Includes patients with secondary (or functional) mitral regurgitation resulting from heart failure.
      Abbott Laboratories 01.20.21

    • Samsara Vision Appoints Three New Board Members

      Samsara Vision Appoints Three New Board Members

      Company recently changed its name from VisionCare Inc.
      Business Wire 01.20.21

    • Diagnostics
      Thermo Fisher Buys Mesa Biotech for $450M

      Thermo Fisher Buys Mesa Biotech for $450M

      Mesa Biotech developed, commercialized a PCR-based rapid POC testing platform for detecting infectious diseases.
      PR Newswire 01.20.21


    • AtriCure Receives FDA Clearance to Expand its Labeling for Cryo Nerve Block Therapy

      AtriCure Receives FDA Clearance to Expand its Labeling for Cryo Nerve Block Therapy

      The expansion includes adolescent patients who can benefit from cryo nerve block therapy during surgical procedures involving the chest wall.
      Business Wire 01.20.21

    • Former Covidien Executive Joins Vesper Medical Board

      Former Covidien Executive Joins Vesper Medical Board

      New board member has over 25 years in sales, marketing and operational leadership roles building innovative technology portfolios.
      Business Wire 01.20.21

    • Ra Medical Pays $2.5 Million to Settle False Claims Investigation

      Ra Medical Pays $2.5 Million to Settle False Claims Investigation

      The company did not admit any liability or wrongdoing.
      Business Wire 01.20.21


    • CHF Solutions Appoints CEO

      CHF Solutions Appoints CEO

      Nestor Jaramillo Jr succeeds John Erb.
      Globe Newswire 01.19.21

    • Surgical
      Freehand Partners with Imperial Medical Solutions

      Freehand Partners with Imperial Medical Solutions

      Supports the introduction of its surgical robots in India, Sri Lanka, Malaysia and the Caribbean.
      Freehand 01.19.21

    • Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant

      Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant

      Establishes new S code for Propel to facilitate specific coding and payment.
      Business Wire 01.19.21


    Trending
    • Telemedicine, Regulatory Changes To Characterize Medtech Industry In 2021
    • Philips Buys Capsule Technologies In $635M Deal
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Haemonetics To Acquire Cardiva For Up To $510M
    • Meeting Critical Ventilator Product Requirements Amid Pandemic
    Breaking News
    • Plitek Adds New Slitting Capacity
    • FDA Grants Emergency Use Authorization for COVID-19 Rapid Antibody Fingerstick Test
    • PhysIQ Elects Former Naval Vice Admiral to its Advisory Board
    • First Heart Failure Patient Treated With Impulse Dynamics' CCM Therapy in Brazil
    • Boston Scientific to Acquire Preventice for Up to $925M
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Astaxanthin Microencapsulated with Spirulina Targets ‘Mental Agility’ and Healthy Aging
    Ingredient Manufacturers Discuss the E-Sports Market
    Euromonitor Names Top Ten Trends for 2021
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Plitek Adds New Slitting Capacity
    FDA Grants Emergency Use Authorization for COVID-19 Rapid Antibody Fingerstick Test
    PhysIQ Elects Former Naval Vice Admiral to its Advisory Board
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Global Biosciences Co. Selects ValGenesis VLMS
    Eisai Appoints Chief Clinical Officer of Oncology Biz
    Nexelis Acquires GSK Vax Lab in Marburg
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    TBM Offers New Turnkey Range—Cocoon Skin
    Firmenich Appoints Chief Consumer & Innovation Officer, Global Perfumery
    Top Beauty Brands in the World—And Most Loved Fragrances
    Happi

    Latest Breaking News From Happi

    Flow Launches Collagen Waters
    Associations Congratulate Biden & Harris
    David Stanko Joins JPMS
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Wemy Donates PPE to Teaching Hospital
    First Quality Launches Incognito by Prevail
    Essity Launches Reusable Underwear Product
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    RIVANNA Launches Second-Generation Accuro With Thoracic Functionality
    DJO Acquires Trilliant Surgical
    FDA Breakthrough Device Designation Granted to Spiderwort's Spinal Cord Technology
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login